Healthpeak Properties (NYSE:DOC) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Healthpeak Properties (NYSE:DOC) released its quarterly earnings data on Tuesday. The real estate investment trust reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05, FiscalAI reports. Healthpeak Properties had a return on equity of 2.87% and a net margin of 8.24%.The business had revenue of $771.58 million for the quarter, compared to the consensus estimate of $725.64 million. During the same quarter in the prior year, the business posted $0.46 EPS. The business’s revenue for the quarter was up 11.1% on a year-over-year basis. Healthpeak Properties updated its FY 2026 guidance to 1.730-1.770 EPS.

Healthpeak Properties Price Performance

Shares of NYSE DOC traded down $0.49 during midday trading on Thursday, hitting $21.30. The company had a trading volume of 3,640,371 shares, compared to its average volume of 8,620,251. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties has a twelve month low of $15.70 and a twelve month high of $22.95. The business has a 50-day simple moving average of $21.12 and a two-hundred day simple moving average of $18.76. The firm has a market capitalization of $14.69 billion, a price-to-earnings ratio of 60.90, a price-to-earnings-growth ratio of 3.36 and a beta of 1.01.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be issued a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 5.7%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 381.25%.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.23% of the company’s stock.

Institutional Investors Weigh In On Healthpeak Properties

Institutional investors have recently modified their holdings of the company. Fiduciary Trust Co grew its holdings in shares of Healthpeak Properties by 4.9% in the 3rd quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after purchasing an additional 644 shares during the last quarter. Quadrant Capital Group LLC boosted its holdings in shares of Healthpeak Properties by 1.9% in the 3rd quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock worth $721,000 after acquiring an additional 718 shares in the last quarter. Corient Private Wealth LLC boosted its holdings in shares of Healthpeak Properties by 1.0% in the 2nd quarter. Corient Private Wealth LLC now owns 104,109 shares of the real estate investment trust’s stock worth $1,823,000 after acquiring an additional 1,010 shares in the last quarter. Victory Financial Group LLC grew its position in Healthpeak Properties by 11.3% during the 3rd quarter. Victory Financial Group LLC now owns 11,189 shares of the real estate investment trust’s stock worth $215,000 after acquiring an additional 1,139 shares during the last quarter. Finally, Integrated Wealth Concepts LLC grew its position in Healthpeak Properties by 7.3% during the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after acquiring an additional 1,231 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Wall Street Analyst Weigh In

DOC has been the topic of a number of research analyst reports. Cantor Fitzgerald lifted their target price on Healthpeak Properties from $20.00 to $23.00 and gave the stock a “neutral” rating in a research report on Thursday. Wells Fargo & Company lifted their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company an “equal weight” rating in a report on Wednesday, July 15th. Weiss Ratings upgraded shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. JPMorgan Chase & Co. increased their price target on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 24th. Finally, Robert W. Baird raised their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Four equities research analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. According to data from MarketBeat, Healthpeak Properties currently has a consensus rating of “Hold” and a consensus price target of $20.97.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.